Edge Therapeutics, Inc. Business Operations Contracts & Agreements

8 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amended and Restated At Market Issuance Sales Agreement dated August 13, 2024 by and between the Company, B. Riley Securities, Inc., and H.C. Wainwright & Co., LLC
Sales Agreements
Edge Therapeutics, Inc.
Biotechnology
NY
2024
First Amendment to Preclinical/Clinical Collaboration and License Agreement dated as of November 22, 2021 by and between PDS Biotechnology Corporation and Farmacore Biotechnology
Collaboration Agreements
Edge Therapeutics, Inc.
Biotechnology
NJ
2022
Amended and Restated Preclinical/Clinical Collaboration and License Agreement dated as of November 30, 2020 by and between PDS Biotechnology Corporation and Farmacore Biotechnology
Collaboration Agreements
Edge Therapeutics, Inc.
Biotechnology
NJ
2022
Amendment No. 1 to Clinical Trial Collaboration and Supply Agreement, dated as of October 28, 2019, by and between PDS Biotechnology Corporation and MSD International GmbH
Collaboration Agreements
Edge Therapeutics, Inc.
Biotechnology
2019
Manufacturing and Supply Agreement by and between the Company and Oakwood Laboratories LLC, dated as of June 30, 2017
Supply Agreements
Edge Therapeutics, Inc.
Biotechnology
DE
2017
Amended and Restated Master Formulation Development Agreement by and between the Company and Oakwood Laboratories LLC, dated as of June 30, 2017
Development Agreements
Edge Therapeutics, Inc.
Biotechnology
NY
2017
Master Formulation Development Agreement by and between the Company and Oakwood Laboratories LLC, dated as of March 12, 2015
Development Agreements
Edge Therapeutics, Inc.
Biotechnology
DE
2016
INDEMNIFICATION AGREEMENT
Indemnification Agreements
Edge Therapeutics, Inc.
Biotechnology
DE
2015